These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36934204)

  • 1. Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron.
    Burkholz S; Rubsamen M; Blankenberg L; Carback RT; Mochly-Rosen D; Harris PE
    Commun Biol; 2023 Mar; 6(1):288. PubMed ID: 36934204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil.
    Freire-Neto FP; Teixeira DG; da Cunha DCS; Morais IC; Tavares CPM; Gurgel GP; Medeiros SDN; Santos DCD; Sales AO; Jeronimo SMB
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010337. PubMed ID: 36191040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
    J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular SARS-CoV-2 surveillance in Bavaria shows no Omicron transmission before the end of November 2021.
    Flechsler J; Eberle U; Dangel A; Hepner S; Wimmer C; Lutmayr J; Konrad R; Berger C; Weise L; Sprenger A; Zeitler J; Paravinja N; Angermeier H; Githure G; Schmidt S; Treis B; Okeyo M; Liebl B; Ackermann N; Sing A;
    Infection; 2022 Jun; 50(3):761-766. PubMed ID: 35230655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.
    Guedes AR; Oliveira MS; Tavares BM; Luna-Muschi A; Lazari CDS; Montal AC; de Faria E; Maia FL; Barboza ADS; Leme MD; Tomazini FM; Costa SF; Levin AS
    Sci Rep; 2023 Jan; 13(1):712. PubMed ID: 36639411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain.
    Rodríguez-Grande C; Estévez A; Palomino-Cabrera R; Molero-Salinas A; Peñas-Utrilla D; Herranz M; Sanz-Pérez A; Alcalá L; Veintimilla C; Catalán P; Martínez-Laperche C; Alonso R; Muñoz P; Pérez-Lago L; de Viedma DG;
    Emerg Infect Dis; 2023 Jun; 29(6):1154-1161. PubMed ID: 37130503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants.
    Özüdoğru O; Bahçe YG; Acer Ö
    Ir J Med Sci; 2023 Apr; 192(2):751-756. PubMed ID: 35711013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.
    Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y
    BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 reinfections during the Delta and Omicron waves.
    Morris CP; Eldesouki RE; Fall A; Gaston DC; Norton JM; Gallagher ND; Luo CH; Abdullah O; Klein EY; Mostafa HH
    JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36048527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil.
    Naveca FG; Nascimento VA; Nascimento F; Ogrzewalska M; Pauvolid-Corrêa A; Araújo MF; Arantes I; Batista ÉR; Magalhães AÁ; Vinhal F; Mattos TP; Riediger I; Debur MDC; Grinsztejn B; Veloso VG; Brasil P; Rodrigues RR; Rovaris DB; Fernandes SB; Fernandes C; Santos JHA; Abdalla LF; Costa-Filho R; Silva M; Souza V; Costa ÁA; Mejía M; Brandão MJ; Gonçalves LF; Silva GA; de Jesus MS; Pessoa K; Corado ALG; Duarte DCG; Machado AB; Zukeram KA; Valente N; Lopes RS; Pereira EC; Appolinario LR; Rocha AS; Tort LFL; Sekizuka T; Itokawa K; Hashino M; Kuroda M; Dezordi FZ; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Bello G; Resende PC
    Sci Rep; 2023 May; 13(1):7306. PubMed ID: 37147348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
    Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
    BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SARS-CoV-2 Variants of Concern Using Amplicon Next-Generation Sequencing.
    Nasereddin A; Golan Berman H; Wolf DG; Oiknine-Djian E; Adar S
    Microbiol Spectr; 2022 Aug; 10(4):e0073622. PubMed ID: 35758686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population.
    Wei J; Stoesser N; Matthews PC; Khera T; Gethings O; Diamond I; Studley R; Taylor N; Peto TEA; Walker AS; Pouwels KB; Eyre DW;
    Nat Commun; 2024 Feb; 15(1):1008. PubMed ID: 38307854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States.
    Wang H; Wright T; Everhart K; Oyeniran SJ; Mejias A; Leber AL
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):198-204. PubMed ID: 37004190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis.
    Ismail NF; Rahman AE; Kulkarni D; Zhu F; Wang X; Del Carmen Morales G; Srivastava A; Allen KE; Spinardi J; Kyaw MH; Nair H
    J Glob Health; 2023 Nov; 13():06051. PubMed ID: 37994839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.
    Guevara R; Prado-Vivar B; Márquez S; Muñoz EB; Carvajal M; Guadalupe JJ; Becerra-Wong M; Proaño S; Bayas-Rea R; Coloma J; Grunauer M; Trueba G; Rojas-Silva P; Barragán V; Cárdenas P
    Front Cell Infect Microbiol; 2022; 12():951383. PubMed ID: 36164552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines.
    Araf Y; Akter F; Tang YD; Fatemi R; Parvez MSA; Zheng C; Hossain MG
    J Med Virol; 2022 May; 94(5):1825-1832. PubMed ID: 35023191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.